International Edition
Latest News
Health

BPOM, Bio Farma Integrate AI to Cut Polio Vaccine Testing Time

Artificial intelligence could soon cut vaccine testing times in half under a new digital pathology initiative pursued by Indonesian regulators and manufacturers. Badan Pengawas Obat dan Makanan teamed up with PT Bio Farma to integrate artificial intelligence into…

BPOM, Bio Farma Integrate AI to Cut Polio Vaccine Testing Time

Artificial intelligence could soon cut vaccine testing times in half under a new digital pathology initiative pursued by Indonesian regulators and manufacturers.

Badan Pengawas Obat dan Makanan teamed up with PT Bio Farma to integrate artificial intelligence into the laboratory analysis of polio vaccines, Antara News reported on Thursday, November 19, 2026, according to Antara News Palu.

The collaboration aims to transform how technicians examine microscopic tissue samples during crucial quality control checks. Regulators want the technology to ease the heavy workload of manual microscopic evaluations.

“Neurovirulen testing itu selama ini punya beberapa keterbatasan, karena selama ini kita tahu dia lihat dari histopatologi bagaimana setelah dilakukan tes,” kata Taruna Ikrar, Kepala BPOM, as reported by detikcom, according to karawang bekasi disway.

Laboratory analysts currently inspect hundreds to thousands of microscopic tissue slides by hand to verify vaccine safety. That manual process introduces human fatigue and potential subjectivity into delicate neurological evaluations.

BPOM, Bio Farma Integrate AI to Cut Polio Vaccine Testing Time
Photo: karawang bekasi disway

Artificial intelligence will assist staff by reading digital histopathology images captured during neurovirulence testing. The system relies on fixed algorithms to evaluate tissue changes according to established global standards.

“Kalau kita estimasikan bisa setengahnya lebih cepat. Itu akan sangat membantu,” ujar Iin Susanti, Direktur Operasi Bio Farma, at a workshop in Bandung on Wednesday, November 18, 2026, according to Pikiran Rakyat Koran.

Bpom Kawal Bio Farma Kembangkan Uji Vaksin Polio Berbasis Artificial Intelligence(Ai) — Garuda TV Jabar

Regulators and manufacturers stress that automated tools must undergo rigorous validation before entering routine laboratory workflows. Bio Farma plans to thoroughly test the technology to guarantee system reliability and robustness.

The implementation timeline spans approximately the next year, requiring both organizations to unify and standardize existing testing data repositories.

“Sebelum menggunakannya dalam pengujian rutin, kami perlu membuktikan bahwa hasil pembacaannya dapat diandalkan,” ujar Iin Susanti, Direktur Operasi Bio Farma, as reported by tugubandung.id.

BPOM, Bio Farma Integrate AI to Cut Polio Vaccine Testing Time
Photo: tugubandung.id

Manual microscopic examination of hundreds or thousands of tissue slides causes analyst fatigue and introduces subjectivity. Automated digital pathology helps laboratories process large sample volumes faster and more consistently.

PT Bio Farma targets the implementation of artificial intelligence within approximately one year, pending thorough validation of system reliability and data standardization with regulators.

The initiative focuses on neurovirulence testing, which evaluates microscopic tissue changes in the nervous system to confirm that vaccine batches remain safe and non-virulent.

About the author: Health Desk

Health Desk at Archynewsy.